Trial intelligence / Profile preview

Effect of Levodopa on mERG

NCT00812760Phase 4Completed

Sponsor
Medical University of Vienna
Start
Oct 2001
Primary completion
Oct 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levodopa in Parkinson's disease (PD), sponsored by Medical University of Vienna. Started Oct 2001; status: completed.

02

Drugs

levodopa
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT00812760.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00812760.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call